Schönfeld et al. showed that NK-92/5.28.z ErbB2 (HER2)-specific NK cells efficiently lysed ErbB2-expressing tumor cells in vitro and were also able to reduce in vivo lung metastasis in a renal cell carcinoma model [229]. This evidence concerns the gene ERBB2 and hereditary clear cell renal cell carcinoma.